CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,253,826
- in 9 filings, $2.1M under 10b5-1 plans
Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-01 | Welgus Howard G. Director | Sale 10b5-1 | −10,000 | $8.65 | $87K | 171,944 |
| 2024-10-02 | Edwards Larry Todd SVP Chief Commercial Officer | Sale 10b5-1 | −3,725 | $10.01 | $37K | 136,635 |
| 2024-10-01 | Welgus Howard G. Director | Sale 10b5-1 | −10,000 | $9.26 | $93K | 181,944 |
| 2024-09-24 | Topper David Joseph Chief Financial Officer | Sale | −11,626 | $9.48 | $110K | 158,374 |
| 2024-09-21 | Topper David Joseph Chief Financial Officer | Grant or award | +60,000 | 170,000 | ||
| 2024-09-03 | Welgus Howard G. Director | Sale 10b5-1 | −10,000 | $10.77 | $108K | 191,944 |
| 2024-08-19 | Burnett Patrick | Sale 10b5-1 | −1,728 | $8.29 | $14K | 194,859 |
| 2024-08-02 | Matsuda Masaru | Sale 10b5-1 | −5,220 | $9.02 | $47K | 183,288 |
| 2024-08-02 | Burnett Patrick | Sale 10b5-1 | −13,206 | $9.02 | $119K | 196,587 |
| 2024-08-02 | Watanabe Todd Franklin | Sale 10b5-1 | −14,487 | $9.02 | $131K | 846,263 |
| 2024-08-01 | Welgus Howard G. Director | Exercise or conversion 10b5-1 | +6,614 | $1.68 | $11K | 186,953 |
| 2024-08-01 | Welgus Howard G. Director | Sale 10b5-1 | −6,614 | $9.87 | $65K | 180,339 |
| 2024-08-01 | Welgus Howard G. Director | Sale 10b5-1 | −3,386 | $9.87 | $33K | 176,953 |
| 2024-08-01 | Welgus Howard G. Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,614 | 0 | ||
| 2024-07-01 | Welgus Howard G. Director | Exercise or conversion 10b5-1 | +5,681 | $1.68 | $10K | 186,020 |
| 2024-07-01 | Welgus Howard G. Director | Exercise or conversion 10b5-1 | +4,319 | $1.68 | $7K | 190,339 |
| 2024-07-01 | Welgus Howard G. Director | Sale 10b5-1 | −10,000 | $9.31 | $93K | 180,339 |
| 2024-07-01 | Welgus Howard G. Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −5,681 | 0 | ||
| 2024-07-01 | Welgus Howard G. Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −4,319 | 6,614 | ||
| 2024-06-14 | Leonard Keith R Director | Grant or award | +10,139 | 18,826 |
Page 17 of 35 · 689 trades